BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23044416)

  • 1. Fibroblast growth factor 2 inhibits up-regulation of bone morphogenic proteins and their receptors during osteoblastic differentiation of human mesenchymal stem cells.
    Biver E; Soubrier AS; Thouverey C; Cortet B; Broux O; Caverzasio J; Hardouin P
    Biochem Biophys Res Commun; 2012 Nov; 427(4):737-42. PubMed ID: 23044416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor 2 inhibits bone morphogenetic protein 9-induced osteogenic differentiation of mesenchymal stem cells by repressing Smads signaling and subsequently reducing Smads dependent up-regulation of ALK1 and ALK2.
    Song T; Wang W; Xu J; Zhao D; Dong Q; Li L; Yang X; Duan X; Liang Y; Xiao Y; Wang J; He J; Tang M; Wang J; Luo J
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1639-46. PubMed ID: 23680673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalk between tyrosine kinase receptors, GSK3 and BMP2 signaling during osteoblastic differentiation of human mesenchymal stem cells.
    Biver E; Thouverey C; Magne D; Caverzasio J
    Mol Cell Endocrinol; 2014 Jan; 382(1):120-130. PubMed ID: 24060635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of osteoblastic differentiation of mesenchymal stromal cells cultured by selective combination of bone morphogenetic protein-2 (BMP-2) and fibroblast growth factor-2 (FGF-2).
    Maegawa N; Kawamura K; Hirose M; Yajima H; Takakura Y; Ohgushi H
    J Tissue Eng Regen Med; 2007; 1(4):306-13. PubMed ID: 18038421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous bone morphogenetic proteins in human bone marrow-derived multipotent mesenchymal stromal cells.
    Seib FP; Franke M; Jing D; Werner C; Bornhäuser M
    Eur J Cell Biol; 2009 May; 88(5):257-71. PubMed ID: 19303661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGF2 stimulates the proliferation of human mesenchymal stem cells through the transient activation of JNK signaling.
    Ahn HJ; Lee WJ; Kwack K; Kwon YD
    FEBS Lett; 2009 Sep; 583(17):2922-6. PubMed ID: 19664626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into BMP-7 mediated osteoblastic differentiation of primary human mesenchymal stem cells.
    Lavery K; Hawley S; Swain P; Rooney R; Falb D; Alaoui-Ismaili MH
    Bone; 2009 Jul; 45(1):27-41. PubMed ID: 19306956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: antagonism by noggin.
    Abe E; Yamamoto M; Taguchi Y; Lecka-Czernik B; O'Brien CA; Economides AN; Stahl N; Jilka RL; Manolagas SC
    J Bone Miner Res; 2000 Apr; 15(4):663-73. PubMed ID: 10780858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour necrosis factor alpha-stimulated gene-6 inhibits osteoblastic differentiation of human mesenchymal stem cells induced by osteogenic differentiation medium and BMP-2.
    Tsukahara S; Ikeda R; Goto S; Yoshida K; Mitsumori R; Sakamoto Y; Tajima A; Yokoyama T; Toh S; Furukawa K; Inoue I
    Biochem J; 2006 Sep; 398(3):595-603. PubMed ID: 16771708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells.
    Luu HH; Song WX; Luo X; Manning D; Luo J; Deng ZL; Sharff KA; Montag AG; Haydon RC; He TC
    J Orthop Res; 2007 May; 25(5):665-77. PubMed ID: 17290432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biphasic effects of transforming growth factor β on bone morphogenetic protein-induced osteoblast differentiation.
    de Gorter DJ; van Dinther M; Korchynskyi O; ten Dijke P
    J Bone Miner Res; 2011 Jun; 26(6):1178-87. PubMed ID: 21611961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunolocalization of BMPs, BMP antagonists, receptors, and effectors during fracture repair.
    Yu YY; Lieu S; Lu C; Miclau T; Marcucio RS; Colnot C
    Bone; 2010 Mar; 46(3):841-51. PubMed ID: 19913648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astragaloside II induces osteogenic activities of osteoblasts through the bone morphogenetic protein-2/MAPK and Smad1/5/8 pathways.
    Kong XH; Niu YB; Song XM; Zhao DD; Wang J; Wu XL; Zhang R; Mei QB
    Int J Mol Med; 2012 Jun; 29(6):1090-8. PubMed ID: 22426655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone Morphogenetic Proteins: Promising Molecules for Bone Healing, Bioengineering, and Regenerative Medicine.
    Carreira AC; Zambuzzi WF; Rossi MC; Astorino Filho R; Sogayar MC; Granjeiro JM
    Vitam Horm; 2015; 99():293-322. PubMed ID: 26279381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced expression of type I receptors for bone morphogenetic proteins during bone formation.
    Ishidou Y; Kitajima I; Obama H; Maruyama I; Murata F; Imamura T; Yamada N; ten Dijke P; Miyazono K; Sakou T
    J Bone Miner Res; 1995 Nov; 10(11):1651-9. PubMed ID: 8592941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor.
    Kanzaki S; Takahashi T; Kanno T; Ariyoshi W; Shinmyouzu K; Tujisawa T; Nishihara T
    J Cell Physiol; 2008 Sep; 216(3):844-50. PubMed ID: 18449905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral factors released from human periodontal ligament cells influence calcification and proliferation in human bone marrow mesenchymal stem cells.
    Mizuno N; Ozeki Y; Shiba H; Kajiya M; Nagahara T; Takeda K; Kawaguchi H; Abiko Y; Kurihara H
    J Periodontol; 2008 Dec; 79(12):2361-70. PubMed ID: 19053928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The proteasome inhibitor bortezomib stimulates osteoblastic differentiation of human osteoblast precursors via upregulation of vitamin D receptor signalling.
    Kaiser MF; Heider U; Mieth M; Zang C; von Metzler I; Sezer O
    Eur J Haematol; 2013 Apr; 90(4):263-72. PubMed ID: 23311753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxysterol-induced osteoblastic differentiation of pluripotent mesenchymal cells is mediated through a PKC- and PKA-dependent pathway.
    Richardson JA; Amantea CM; Kianmahd B; Tetradis S; Lieberman JR; Hahn TJ; Parhami F
    J Cell Biochem; 2007 Apr; 100(5):1131-45. PubMed ID: 17031848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cartilage-derived morphogenetic proteins enhance the osteogenic protein-1-induced osteoblastic cell differentiation of C2C12 cells.
    Yeh LC; Tsai AD; Zavala MC; Lee JC
    J Cell Physiol; 2004 Dec; 201(3):401-8. PubMed ID: 15389555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.